VISTA+/CD8+ status correlates with favorable prognosis in Epithelial ovarian cancer

Immunotherapy by blocking immune checkpoint regulators has emerged as a new targeted therapy for some cancers. Among them V-domain Ig suppressor of Tcell activation (VISTA) which is identified as a novel checkpoint regulator in ovarian cancer. This study aimed to investigate the VISTA role in Epithe...

Descripción completa

Detalles Bibliográficos
Autores principales: Jlassi, Aida, Manai, Maroua, Morjen, Maram, Sahraoui, Ghada, Elasmi Allal, Monia, ELBini-Dhouib, Ines, Naija, Lamia, Charfi, Lamia, Rejaibi, Rim, Ben Ahmed, Melika, Marrakchi, Naziha, Srairi-Abid, Najet, Mezlini, Amel, Manai, Mohamed, Mrad, Karima, Doghri, Raoudha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035885/
https://www.ncbi.nlm.nih.gov/pubmed/36952478
http://dx.doi.org/10.1371/journal.pone.0278849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035885/
https://www.ncbi.nlm.nih.gov/pubmed/36952478
http://dx.doi.org/10.1371/journal.pone.0278849

Ejemplares similares